Predictors of Sustained Ventricular Arrhythmias in Cardiac Resynchronization Therapy

DSpace/Manakin Repository

Predictors of Sustained Ventricular Arrhythmias in Cardiac Resynchronization Therapy

Citable link to this page

 

 
Title: Predictors of Sustained Ventricular Arrhythmias in Cardiac Resynchronization Therapy
Author: Friedman, D. J.; Altman, R. K.; Orencole, M.; Picard, Michael Howard; Ruskin, Jeremy Neil; Singh, Jagmeet P.; Heist, Edwin Kevin

Note: Order does not necessarily reflect citation order of authors.

Citation: Friedman, D. J., R. K. Altman, M. Orencole, M. H. Picard, J. N. Ruskin, J. P. Singh, and E. K. Heist. 2012. “Predictors of Sustained Ventricular Arrhythmias in Cardiac Resynchronization Therapy.” Circulation: Arrhythmia and Electrophysiology 5 (4) (July 11): 762–772. doi:10.1161/circep.112.971101.
Full Text & Related Files:
Abstract: Background: Patients undergoing cardiac resynchronization therapy (CRT) are at high risk for ventricular arrhythmias and risk stratification in this population remains poor. Methods and Results: This study followed 269 patients (LVEF < 35%, QRS > 120ms, NYHA III/IV) undergoing CRT with defibrillator (CRT-D) for 553±464 days after CRT-D implantation to assess for independent predictors of appropriate device therapy for ventricular arrhythmias (VAs). Baseline medication use, medical comorbidities, and echocardiographic parameters were considered. The 4-year incidence of appropriate device therapy was 36%. A Cox proportional hazard model identified left ventricular end systolic diameter (LVESD) > 61mm as an independent predictor in the entire population (HR 2.66, p = 0.001). Those with LVESD > 61mm had a 51% 3-year incidence of VA compared to a 26% incidence among those with a less dilated ventricle (p = 0.001). Among patients with LVESD ≤61mm, multivariate predictors of appropriate therapy were absence of beta-blocker therapy (HR 6.34, p<0.001, LVEF < 20% (HR 4.22, p <0.001), and history of sustained VA (2.97, p = 0.013). Early (<180d after implant) shock therapy was found to be a robust predictor of heart failure hospitalization (HR 3.41, p < 0.004) and mortality (HR 5.16 p < 0.001.) Conclusions: Among CRT-D patients, LVESD > 61mm is powerful predictor of ventricular arrhythmias and further risk stratification of those with less dilated ventricles can be achieved based on assessment of EF, history of sustained VA, and absence of beta-blocker therapy.
Published Version: doi:10.1161/CIRCEP.112.971101
Other Sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766722/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:29048906
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters